spacer
home > ebr > autumn 2009 > diagnostics in context
PUBLICATIONS
European Biopharmaceutical Review

Diagnostics in Context

 

Manuel Silva is a volunteer community health worker in the Peruvian Amazon. His village lies about 20km from the region’s largest city, Iquitos. I met Manuel 10 years ago while working on a malaria control project in his area. He is part of a cadre of volunteer community health workers (CHWs) recruited by the Peruvian Ministry of Health in the mid-1990s to provide malaria case management in remote areas with limited access to health facilities. Like most CHWs in Peru and elsewhere, Manuel is not paid for his work. A subsistence farmer, he spends most of his time tending his crops. He tends to his neighbours’ health when he is not in his fields.

When he first began working as a CHW, Manuel was trained to prepare blood slides for malaria diagnosis. But his training ends there: he can only prepare the slide, not read it. Even if he could read it, there are no microscopes in his village, no stains or reagents – in fact, there’s not even any electricity.

So Manuel has to take the slide to a microscopy-capable health facility. When I first started working with Manuel, the nearest facility with a microscope was about an hour’s walk away, but that facility had no microscopist. The nearest facility with both a microscope and a technician sufficiently trained to use it was another 30 to 40 minutes bus journey. The maths is eye-opening: an hour and a half to the health centre, an hour and a half to get back, add in the wait for the bus and the time to prepare the slide and Manuel has lost half day’s work in the field. This might not be an undue hardship for the occasional patient, but in high transmission season when Manuel sees multiple patients per day and many over the course of a week, leaving the fields daily to transport slides to the nearest microscopy-capable health facility would leave Manuel’s crops in ruin and his family with nothing to eat.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Steven A Harvey is Senior Malaria Advisor at University Research Co, LLC, and the Center for Human Services, and Principal Investigator of the Diagnostics Cost Analysis for the Developing World study, funded by the Bill & Melinda Gates Foundation to assess developing country diagnostics needs in malaria, HIV/AIDS, tuberculosis, syphilis, gonorrhoea, chlamydia and acute lower respiratory infection. He has 15 years of public health research experience in Africa, Asia, Latin America and the US, and holds a PhD in international health from the Johns Hopkins Bloomberg School of Public Health.
spacer
Steven A Harvey
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera announces a better drug deposition with RetroNose to enhance therapeutic efficacy of nasal treatments

After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is happy to publish enhanced drug deposition results compared to classic nasal sprays with RetroNose.
More info >>

White Papers

The Promise and Challenge of Adaptive Design in Oncology Trials

Medpace

Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research. Incorporating adaptive design methodologies into clinical trials can reduce costs and enhance efficiency while maintaining trial integrity. They can also reduce the number of patients on placebo and sub-therapeutic doses. In light of this promise, regulatory bodies have created guidelines supportive of adaptive design.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement